维普中文期刊产品整合服务
33篇 您的检索式:作者名="Kapitza C"
    题名 作者 年代 出处 被引量
1The once-daily human GLP-1 analogue liraglutide impacts appetite and energy intake in patients with type 2 diabetes after short-term treatment 显示文摘Flint A Kapitza C Zdravkovic M 2013Diabetes Obes Metab2013,15,10:1
2Reduction of myocardial infarct size by fluvastatin显示文摘 Kapitza J Dietz V 2003Am J Physiol Heart Circ Physiol2003,285,1:1
3Absorption and metabolic effect of inhaled insulin: intrapatient variability after inhalation via the Aerodose insulin inhaler in patients with type 2 diabetes 显示文摘Perera AD Kapitza C Nosek L 2002Diabetes Care2002,25,12:1
4Changes in basal insulin infusion: time until a change in metabolic effect is induced in patients with type 1 diabetes 显示文摘Heinemann L Nosek L Kapitza C 2009Diabetes Care2009,32,8:1
5Reduction of myocardial infarct size by fluvastatin显示文摘Tiefenbacher C P Kapitza J Dietz V 2003Am J Physiol Heart Cire Physio2003,285,3:1
6Reduction of myocardial ifarct size by fluvastain 显示文摘Iefenbacher C P Kapitza J Dietz V 2003Am J Physiol Heart Circ Phyaiol2003,285,1:1
7Microneedle-based intradermal versus subcutaneous administration of regular hu- man insulin or insulin lispro : pharmacokinetics and postpran- dial glycemic excursions in patients with type 1 diabetes显示文摘Pettis R J Hirsch L Kapitza C 2011Diabetes Technol Ther2011,13,4:1
8The effect of the once-daily human glucagon-like peptide 1 analog liraglutide on the pharmacokinetics of acetaminophen显示文摘Kapitza C Zdravkovic M Hindsberger C 2011Adv Ther2011,28,8:1
9Reduced postprandial glycaemic excursion with biphasic insulin Aspart 30 injected immediately before a meal显示文摘Kapitza C Rave K Ostrowski K 2004Diabet Med2004,21,5:1
10The once-daily human GLP-1 analogue liraglutide impacts appetite and energy intake in pa tients with type 2 diabetes after short-term treatment显示文摘Flint A Kapitza C Zdravkovic M 2013Dia- betes Obes Metab2013,15,10:1
11Reduced postprandial glycaemic excursion with biphasic insulin Aspart 30 injected immediately before a meal显示文摘Kapitza C Rave K Ostrowski K 2005Diabetes Care2005,29,:1
12Safety and tolerability of high doses of taspoglutide, a once-weekly human GLP-1 analogue, in diabetic patients treated with metformin: A randomized double-blind placebo-controlled study显示文摘RATNER R NAUCK M KAPITZA C 2010Diabet Med2010,27,5:1
13Time-action profile of the insulin analogue B28Asp显示文摘Heinemann L Kapitza C Starke AA 1996Diabet Med1996,13,7:1
14Treatment with the human once-weekly glucagon-like peptide-1 analog taspoglutide in combination with metformin improves glycemic control and lowers body weight in patients with type 2 diabetes inadequately controlled with metformin alone:A double-blind placebo-controlled study显示文摘Nauck MA Ratner RE Kapitza C 2009Diabetes Care2009,32,7:1
15Safety and tolerability of high doses of taspoglutide,a once-weekly human GLP-1 analogue,in diabetic patients treated with metformin:A randomized double-blind placebo-controlled study显示文摘Ratner R Nauck M Kapitza C 2010Diabetic Medicine2010,27,5:1
16Safety and tolerability of high doses of taspoglutide,a once-weekly human GLP-1 analogue,in diabetic patients treated with metformin:a randomized double-blind placebo-controlled study显示文摘Ratner R Nauck M Kapitza C 2010Diabet Med2010,27,5:1
17The effect of the once-daily human GLP-1 analogue iiraglutide on the pharmacokinetics of paracetamol 显示文摘KAPITZA C FLINT A HINDSBERGER C 2008Diabetes2008,57,:1
18Treatment with the human once-weekly glucagon-like peptide-1 analog taspoglutide in combination with metformin improves glycemic control and lowers body weight in patients with type 2 diabetes inadequately controlled with metformin alone: a double-blind placebo-controlled study 显示文摘Nauck M A Ratner R E Kapitza C 2009Diabetes Care2009,32,7:1
19The once-daily human GLP-1 analogue liraglutide improves both absolute and baseline corrected postprandial glucose levels显示文摘Flint A Kapitza C Hindsberger C 2008Diabetes2008,57,1:1
20Reduced postprandial glycaemic xcursion with biphasic insulin Aspart 30 injected immediately before a meal显示文摘Kapitza C Rave K Ostrowski K 2004Diabet Med2004,21,5:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费